Aihan Zhang

Develops bioinformatics pipelines integrating genomic, transcriptomic and immunopeptidomic datasets to identify candidate neoantigens for preventive cancer vaccines. Research focuses on characterising naturally occurring anti-tumour immunity in precancerous lesions through multi-omics analyses, advancing translational strategies for cancer interception and prevention.

Dr Zhang obtained a PhD in 2024 from the Institute of Healthy Ageing at University College London (UCL), where the research focused on ageing-related signalling pathways and their roles in age-associated diseases and cancer. The work involved gene expression analysis, identification of therapeutic targets, and the development of liposome-based vaccine delivery systems aimed at modulating key molecular pathways involved in tumourigenesis and ageing.